The Cooper Companies, Inc. $COO Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 15.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 338,750 shares of the medical device company’s stock after selling 60,441 shares during the quarter. California Public Employees Retirement System’s holdings in Cooper Companies were worth $24,221,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in COO. New York Life Investment Management LLC grew its stake in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after purchasing an additional 158 shares during the last quarter. Root Financial Partners LLC raised its holdings in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Allworth Financial LP lifted its stake in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after purchasing an additional 167 shares during the last quarter. Blue Trust Inc. lifted its stake in Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after purchasing an additional 185 shares during the last quarter. Finally, SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

COO opened at $70.50 on Thursday. The company has a market cap of $13.75 billion, a PE ratio of 59.75, a price-to-earnings-growth ratio of 1.86 and a beta of 0.84. The stock has a 50-day moving average of $66.93 and a 200-day moving average of $72.28. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same period last year, the business earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of several research reports. Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. BNP Paribas Exane cut their target price on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Finally, Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.